FDA Drug Info Rounds pharmacists discuss the key differences between the laws and regulations for drugs and cosmetics.

FDA Drug Info Rounds pharmacists discuss the legal requirements for the over-the-counter purchase of drug products that contain pseudoephedrine.

FDA Drug Info Rounds pharmacists discuss some simple steps to take if a potential victim receives an extortion call from FDA impersonators.

FDA Drug Info Rounds pharmacists discuss the FDA’s new and improved REMS website called REMS@FDA.

FDA Drug Info Rounds pharmacists discuss breakthrough therapy designation, an exciting new program to expedite drug development.

FDA Drug Info Rounds pharmacists discuss how patients and pharmacists can play an important role in combating antibiotic resistance.

FDA Drug Info Rounds Pharmacists discuss why medication adherence is so important.

FDA Drug Info Rounds pharmacists provide some background information about the FAERS database.

FDA Drug Info Rounds pharmacists discuss changes to the online National Drug Code (or NDC) Directory.

FDA Drug Info Rounds pharmacists discuss the many components of Risk Evaluation and Mitigation Strategies (REMS) and how they can help manage a drug product with known or potential serious risks.